InspireMD, Inc. — Director's Dealing 2023

Aug 30, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2023-08-28

Reporting Person: Gleason Shane Thomas (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-28	Common Stock	A	19290	—	Acquired	275740	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-28	Options to purchase common stock (right to buy)	$3.37	A	6430	Acquired	2033-08-28	Common Stock (6430)	Direct

Footnotes

F1: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 28, 2024, August 28, 2025 and August 28, 2026, subject to the Reporting Person's continued service.

F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 28, 2024, August 28, 2025 and August 28, 2026, subject to the Reporting Person's continued service.